[HTML][HTML] COVID-19-associated opportunistic infections: a snapshot on the current reports

A Abdoli, S Falahi, A Kenarkoohi - Clinical and experimental medicine, 2022 - Springer
Abstract Treatment of the novel Coronavirus Disease 2019 (COVID-19) remains a
complicated challenge, especially among patients with severe disease. In recent studies …

[HTML][HTML] Cytokine storm in COVID-19: immunopathogenesis and therapy

C Zanza, T Romenskaya, AC Manetti, F Franceschi… - Medicina, 2022 - mdpi.com
A cytokine storm is a hyperinflammatory state secondary to the excessive production of
cytokines by a deregulated immune system. It manifests clinically as an influenza-like …

[HTML][HTML] Opportunistic infections in COVID-19: a systematic review and meta-analysis

N Kurra, PI Woodard, N Gandrakota, H Gandhi… - Cureus, 2022 - ncbi.nlm.nih.gov
The prevalence, incidence, and characteristics of bacterial infections in patients infected with
severe acute respiratory syndrome coronavirus 2 are not well understood and have been …

Immune dysregulation and system pathology in COVID-19

M Jamal, HI Bangash, M Habiba, Y Lei, T Xie, J Sun… - Virulence, 2021 - Taylor & Francis
ABSTRACT The coronavirus disease 19 (COVID-19) caused by the novel coronavirus
known as SARS-CoV-2 has caused a global public health crisis. As of 7 January 2021 …

[HTML][HTML] Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment

M Soy, G Keser, P Atagündüz, F Tabak… - Clinical …, 2020 - Springer
COVID-19 infection has a heterogenous disease course; it may be asymptomatic or causes
only mild symptoms in the majority of the cases, while immunologic complications such as …

Attenuating the effects of novel COVID-19 (SARS-CoV-2) infection-induced cytokine storm and the implications

AB Rowaiye, OA Okpalefe… - Journal of …, 2021 - Taylor & Francis
The COVID-19 pandemic constitutes an arduous global health challenge, and the
increasing number of fatalities calls for the speedy pursuit of a remedy. This review …

COVID‐19 immunopathology: from acute diseases to chronic sequelae

M Arish, W Qian, H Narasimhan… - Journal of medical …, 2023 - Wiley Online Library
The clinical manifestation of coronavirus disease 2019 (COVID‐19) mainly targets the lung
as a primary affected organ, which is also a critical site of immune cell activation by severe …

COVID-19 in immunocompromised hosts: what we know so far

M Fung, JM Babik - Clinical Infectious Diseases, 2021 - academic.oup.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused significant morbidity and …

[HTML][HTML] COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies

JD Goldman, PC Robinson, TS Uldrick… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
SARS-CoV-2 is the virus responsible for the COVID-19 pandemic. COVID-19 has highly
variable disease severity and a bimodal course characterized by acute respiratory viral …

[HTML][HTML] Overview on the prevalence of fungal infections, immune response, and microbiome role in COVID-19 patients

M Roudbary, S Kumar, A Kumar, L Černáková… - Journal of Fungi, 2021 - mdpi.com
Patients with severe COVID-19, such as individuals in intensive care units (ICU), are
exceptionally susceptible to bacterial and fungal infections. The most prevalent fungal …